Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study

Funda Meric‐Bernstam, Muralidhar Beeram, Erika Hamilton, Do‐Youn Oh, Diana L. Hanna, Yoon‐Koo Kang, Elena Elimova, Jorge Chaves, Rachel Goodwin, Jeeyun Lee, Lisle Nabell, Sun Young Rha, José Mayordomo, Anthony B. El-Khoueiry, Shubham Pant, Kanwal Pratap Singh Raghav, Jin Won Kim, Amita Patnaik, Todd Gray, R. H. Davies, Mark A. Ozog, Joseph Woolery, Keun‐Wook Lee